World Health Organisation

Sanofi renews WHO partnership on Neglected Tropical Diseases

15-Dec-2020 By Rachel Arthur

Sanofi has made a new five-year, $25m partnership agreement with the World Health Organization (WHO) to fight Neglected Topical Diseases (NTD); and eliminate sleeping sickness by 2030.

WHO indicates preferred HIV treatment

01-Aug-2019 By Vassia Barba

Citing evidence from two completed clinical trials, the WHO recommends dolutegravir as the preferred treatment for all patients with HIV.

update - WHO outlines biosimilarity requirements and inspection plan

WHO plans biosimilar prequalification scheme to increase access to cancer meds

04-May-2017 By Gareth Macdonald

The WHO has announced plans to extend its prequalification scheme to include cancer biosimilars and says it will pressure industry for fairer prices for all biologics.